REDEEMABLE CONVERTIBLE PREFERRED STOCK ESCROWED PROCEEDS AND STOCKHOLDERS (DEFICIENCY) EQUITY (Tables)

9 Months Ended

Mar. 31, 2024

REDEEMABLE CONVERTIBLE PREFERRED STOCK ESCROWED PROCEEDS AND STOCKHOLDERS EQUITY

Equity Distribution Agreement

	Three Months Ended March 31, 2024				Nine Months Ended March 31, 2024					Cumulative from inception
	Shares		Proceeds		Shares		Proceeds			Shares		Proceeds
Gross proceeds		-	$	-		217,027	$	547,803			721,061	$	1,744,542
Fees		-		-		-		(16,434	)		-		(52,336	)
Expenses		-		-		-		-			-		(126,800	)
Net proceeds		-	$	-		217,027	$	531,369			721,061	$	1,565,406

Outstanding Stock Purchase Warrants

	Shares of Common		Exercise Price per		Latest Expiration
Description	Stock		Share		Date
May 2022 Warrants		66,666	$	12.50	May 11, 2026
October 2022 Private Warrants		1,818,182	$	5.83	May 2, 2028
October 2022 Placement Agent Warrants		90,909	$	6.88	October 31, 2027
October 2023 Private Warrants		2,358,491	$	2.12	October 29, 2028
October 2023 Placement Agent Warrants		117,925	$	2.65	October 29, 2028
January 2024 Private Warrants		1,831,503	$	5.46	February 1, 2028
January 2024 Placement Agent Warrants		91,575	$	6.83	February 1, 2028

Weighted average assumption

	June 30, 2023
Expected term		4.84
Volatility		82.35	%
Risk-free rate		4.16	%

Stock option activity

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Term in Years		Aggregate Intrinsic Value
Outstanding - June 30, 2023		1,550,600	$	8.27		8.4
Granted		-		-
Forfeited		-		-
Exercised		-		-
Expired		-		-
Outstanding - March 31, 2024		1,550,600	$	8.27		7.6	$	-
Exercisable at March 31, 2024		561,688	$	14.18		5.8	$	-
Expected to vest at March 31, 2024		988,912	$	4.91		8.7	$	-

Restricted Stock Units

Outstanding at June 30, 2023	987,521
Granted	-
Forfeited	(2,302	)
Expired	(18,000	)
Vested	(98,372	)
Outstanding at March 31, 2024	868,847